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Expression profile of a 
Caenorhabditis elegans model of 
adult neuronal ceroid lipofuscinosis 
reveals down regulation of 
ubiquitin E3 ligase components
Hannah V. McCue, Xi Chen†, Jeff W. Barclay, Alan Morgan & Robert D. Burgoyne
Cysteine string protein (CSP) is a chaperone of the Dnaj/Hsp40 family of proteins and is essential for 
synaptic maintenance. Mutations in the human gene encoding CSP, DNAJC5, cause adult neuronal 
ceroid lipofucinosis (ANCL) which is characterised by progressive dementia, movement disorders, 
seizures and premature death. CSP null models in mice, flies and worms have been shown to also 
exhibit similar neurodegenerative phenotypes. Here we have explored the mechanisms underlying 
ANCL disease progression using Caenorhaditis elegans mutant strains of dnj-14, the worm orthologue 
of DNAJC5. Transcriptional profiling of these mutants compared to control strains revealed a broad 
down-regulation of ubiquitin proteasome system (UPS)-related genes, in particular, components 
of multimeric RING E3 ubiquitin ligases including F-Box, SKR and BTB proteins. These data were 
supported by the observation that dnj-14 mutant worm strains expressing a GFP-tagged ubiquitin 
fusion degradation substrate exhibited decreased ubiquitylated protein degradation. The results 
indicate that disruption of an essential synaptic chaperone leads to changes in expression levels of 
UPS-related proteins which has a knock-on effect on overall protein degradation in C. elegans. The 
specific over-representation of E3 ubiquitin ligase components revealed in our study, suggests that 
proteins and complexes upstream of the proteasome itself may be beneficial therapeutic targets.
Protein misfolding and aggregation have been implicated in the progression of a number of neurode-
generative disorders including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, and prion 
disorders1. It is therefore thought that maintaining correct protein homeostasis is important in the pre-
vention of neurodegeneration. Various studies have identified genetic and pharmacological interventions 
which confer a neuroprotective effect by targeting molecular chaperones, proteasomes and autophagy 
pathways1–3.
Cysteine String Protein (CSP)4 is a co-chaperone of the DnaJ/Hsp40 family of proteins present on 
synaptic and secretory vesicles which is encoded by the DNAJC5 gene in humans5–8. CSP is essential 
for synaptic maintenance and mutations in the DNAJC5 gene cause adult neuronal ceroid lipofuscinosis 
(ANCL)9–12. Clinical symptoms of ANCL include generalized epilepsy, movement disorders, progressive 
dementia and premature death11.
Mouse dnajc5 null mutants are also characterized by age-dependent sensorimotor dysfunction, neu-
rodegeneration and premature mortality13. In particular, studies using CSP-deficient mice have revealed 
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an activity-dependent impairment of synaptic function suggesting that CSP may act to maintain func-
tional SNARE complexes which are essential for neurotransmitter release14. The fastest synaptic degen-
eration occurs in photoreceptor ribbon synapses15 and GABAergic synapses16 whereas degeneration at 
neuromuscular junctions develops more slowly17. Indeed, there is a 50% decrease in levels of the essen-
tial SNARE protein, SNAP-25, in CSP knockout (KO) mice and a corresponding decrease in SNARE 
complex assembly18. In addition, overexpression of SNAP-25 in CSP KO mice was able to rescue the 
neurodegenerative phenotype19. These findings have suggested that SNAP-25 is the major client for the 
chaperone activity of CSP. It is likely that SNAP-25 adopts abnormal conformations during synaptic 
activity, which, if not corrected by CSP chaperone activity, impair SNARE complex assembly leading to 
neurodegeneration20. In the absence of CSP these abnormal conformers are shown to be ubiquitylated 
and targeted for proteasome degradation21. In addition to its function in synaptic vesicle exocytosis, a 
role in endocytosis and synaptic vesicle recycling has also been suggested and CSP has been shown to 
regulate the polymerization of dynamin I17,22.
CSP-deficient models have also been developed in flies and worms23–26. These animals exhibit progres-
sive neurodegeneration and reduced lifespan indicating a conserved function for CSP from invertebrates 
to higher mammals. Caenorhabditis elegans models have proven useful for the study of neurodegenera-
tive diseases due to their genetic tractability, cost effectiveness and short life cycle27–29. Often, however, 
in the absence of a worm orthologue, human genes containing disease-associated mutations are exog-
enously, overexpressed in these models30,31. Models of CSP dysfunction in worms, on the other hand, 
are based on mutations in an endogenously encoded CSP orthologue, dnj-14, which exhibits over 40% 
identity within the J-domain and cysteine string domain when compared to human CSP25. C. elegans 
models of CSP dysfunction more closely mimic the progression of the disease state in humans due to the 
progressive nature of the degenerative phenotypes into adulthood, whereas fly and mouse null models 
have proven lethal at a much earlier age23,13. Additionally, C. elegans mutants have been maintained over 
hundreds of generations which may allow selective pressures to exert effects and reveal compensatory 
changes in gene expression that might not be observed in mouse KO models that have been maintained 
for a single generation only.
In CSP-deficient mice proteasome inhibitors were found to prevent the decrease in SNAP-25 levels 
and SNARE complex assembly and to increase life-span21. As CSP function is conserved from worms 
to man, elucidation of the mechanisms and regulators of CSP-dependent pathways in worms may illu-
minate general aspects of normal neuroprotective pathways that could be targeted in the treatment of 
neurodegenerative diseases. We have, therefore used the model organism, C. elegans, to identify potential 
novel regulators of mutant-CSP mediated neurodegeneration. Transcriptional profiling of two dnj-14 
mutant variants revealed a broad downregulation of ubiquitin-proteasome system (UPS) related genes. 
In particular, genes encoding several key components of multimeric RING finger E3 ubiquitin ligase 
complexes were overrepresented in the down-regulated transcripts. In support of this we observed a 
decrease in ubiquitylated protein degradation in dnj-14 mutant nematodes.
Results
Experimental design. The C. elegans genome encodes a single homologue, dnj-14, of the human 
DNAJC5 gene25. We have previously characterised two mutant C. elegans strains which contain variants 
of the dnj-14 gene25. One variant, dnj-14(ok237), contains a 2229 bp deletion that eliminates the majority 
of the dnj-14 coding region, its putative promoter and part of the adjacent glit-1 gene. The other variant, 
dnj-14(tm3223), contains a 233 bp deletion and an insertion of five adenines within exon 2 of dnj-14. 
Previous work has revealed that both mutant strains exhibit shortened lifespan, age-dependent impair-
ment of locomotion and neurotransmission, and neurodegeneration of sensory neurons coupled with a 
progressive decline in chemosensory behaviour25.
To gain further insight into the genetic mechanisms underlying the pathologic effects of mutations in 
dnj-14 and thus better understand how wild-type dnj-14 helps to protect against neurodegeneration in 
wild-type animals, a whole genome C. elegans microarray was performed (ArrayExpress accession num-
ber: E-MTAB-3147). Global transcription levels of the two dnj-14 mutant strains were compared to two 
control strains, N2 (Bristol) wild-type and CZ1200 (juIs76 [punc-25::GFP + lin-15(+ )] II), which was 
selected as a superficially wildtype strain that was readily available in the lab. CZ1200 stably expresses 
[punc-25::GFP + lin-15(+ )]II, which rescues the effects of a mutation, n765, in the gene encoding the 
transcription factor lin-15. The use of both two control and two experimental strains ensured a high level 
of stringency when identifying differentially expressed genes (DEGs) in the resultant dataset. Previous 
work identified a progressive chemosensory defect that is already severe in day 6 adult worms but which 
precedes visible abnormalities in sensory neuron morphology25. Therefore total RNA samples from the 
four C. elegans strains were isolated from synchronized worms which had been aged until day 6 of 
adulthood. This allowed us to assess global transcriptional changes that occur specifically at the onset 
of neuronal signalling impairment but prior to neuronal cell damage as evidenced by accumulation of 
aggregates and loss of neurons in dnj-14 mutants expressing GFP pan-neuronally25.
Differentially regulated genes in dnj-14 mutant strains. Twelve samples were hybridized to 
arrays consisting of 22,625 probes representing 20,149 predicted C. elegans open reading frames. The 
data were analysed in order to identify genes which were commonly up- or down-regulated in both 
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dnj-14 mutant strains compared to either of the two control samples (Supplementary Table S1 and 
Supplementary Fig. S1). Both 5% and 1% false discovery rate (FDR) datasets were analysed in order to 
ensure the highest confidence in the observed enriched genes and pathways whist ensuring there was 
no loss of representation of DEGs at higher stringency levels. At 5% FDR, 3569 DEGs were revealed 
compared to N2 (Bristol) and 506 DEGs compared to CZ1200. Further analysis of these data identified 
50 Up-regulated and 240 down-regulated DEGs which were common to both control strain datasets 
(Fig. 1A). DAVID functional annotation analysis showed no significantly enriched gene ontology (GO), 
Interpro protein domain or KEGG (Kyoto Encyclopaedia of Genes and Genomes) Pathway terms in 
the up-regulated genes. However, the down-regulated genes showed over-representation of a number of 
terms as shown in Table 1. The GO terms with the lowest P-values were ‘regulation of transcription, DNA 
Figure 1. Venn Diagrams and a heatmap representing differentially regulated genes. (A) Venn diagrams 
illustrating the number of up and down-regulated genes for both the 5% and 1% FDR datasets in dnj-14 
mutants compared to either N2 or CZ1200 and the number of common genes between the two control 
strains. (B) Microarray data heatmap illustrating the log2 fold change of DEGs (FDR < 0.01) common to 
both, tm3223 and ok237, dnj-14 mutant strains compared to N2 and CZ1200 control strains. Each row 
represents one of 213 genes, and each column represents the comparison of each mutant strain to each 
control strain. The column on the left clusters the samples based on similarity in fold change among the  
4 samples. Green color represents a lower log2 fold change while red illustrates a higher log2 fold change. 
The scale on the right matches colours to log2 fold change values.
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dependent’, ‘regulation of RNA metabolic process’ and ‘ubiquitin-dependent protein catabolic process’ 
for Biological Process and terms relating to ‘transcription factor activity’ for Molecular Function. There 
were no GO terms for Cellular Component with a P-value less than 0.01, therefore any terms identified 
were discounted in this analysis. KEGG pathway analysis revealed a greater than 8-fold enrichment for 
‘ubiquitin mediated proteolysis’ consistent with this dataset being enriched for genes related to the UPS. 
Interpro analysis showed over-representation of a number of protein domain classes including F-Box 
proteins, BTB proteins and SKp1-related (Skr) proteins which are all components of multimeric RING 
finger E3 ubiquitin ligase complexes. Additionally, DAVID Functional Annotation Clustering, which 
clusters genes based on functionally similar terms from the dataset, also identified an over-representation 
of F-Box related genes with a high enrichment score of 30.65.
Increasing the stringency by decreasing the FDR to 1% reduced the number of DEGs common to both 
controls to 31 upregulated and 182 down-regulated genes (Fig. 1A,B). Reanalysis of the down-regulated 
genes using DAVID Functional Annotation still revealed similarly enriched annotation terms for the UPS 
pathway in GO, KEGG Pathways and Interpro domains (Table  1). Notably the Biological Process GO 
term, ‘ubiquitin-dependent protein catabolic process’ had a lower P-value and higher fold enrichment 
Annotation Term
5% FDR 1% FDR
P-Value
Fold 
Enrichment P-Value
Fold 
Enrichment
Biological Process
GO:0006355~regulation of transcription, DNA-dependent 1.33E-04 2.80 0.003985128 2.64
GO:0051252~regulation of RNA metabolic process 1.40E-04 2.78 0.004123515 2.63
GO:0006511~ubiquitin-dependent protein catabolic process 1.49E-04 8.51 2.45E-04 10.32
GO:0045449~regulation of transcription 4.50E-04 2.43 0.016440945 2.17
GO:0044265~cellular macromolecule catabolic process 0.0014285 4.67 0.006409969 4.96
GO:0019941~modification-dependent protein catabolic process 0.002640061 4.94 0.002855343 6.00
GO:0043632~modification-dependent macromolecule catabolic 
process 0.002640061 4.94 0.002855343 6.00
GO:0042464~dosage compensation, by hypoactivation of X 
chromosome 0.003032918 34.84 — —
GO:0051603~proteolysis involved in cellular protein catabolic 
process 0.003323413 4.72 0.003485241 5.72
GO:0044257~cellular protein catabolic process 0.003430888 4.69 0.003582778 5.69
GO:0007549~dosage compensation 0.003768035 31.35 — —
GO:0009057~macromolecule catabolic process 0.003815176 3.93 0.013037275 4.17
GO:0030163~protein catabolic process 0.005373442 4.28 0.005292688 5.19
GO:0010171~body morphogenesis 0.007835542 2.33 — —
GO:0007530~sex determination 0.049688021 8.25 — —
GO:0006508~proteolysis 0.054970961 2.01 0.020161301 2.56
Molecular Function
GO:0003700~transcription factor activity 6.23E-05 3.08 1.19E-03 3.04
GO:0030528~transcription regulator activity 7.45E-05 2.77 6.70E-03 2.44
GO:0003677~DNA binding 7.43E-04 2.23 7.13E-03 2.18
KEGG Pathway cel04120:Ubiquitin mediated proteolysis 5.46E-05 8.32 2.42E-05 11.89
Protein Domain (Interpro)
IPR012885:F-Box associated type 2 3.15E-42 21.09 1.50E-41 24.24
IPR001810:Cyclin-like F-Box 7.41E-30 9.37 3.79E-28 10.30
IPR011333:BTB/POZ fold 2.87E-10 8.91 1.88E-09 9.66
IPR001699:Transcription factor, T-box 2.08E-09 33.51 3.46E-05 25.97
IPR016897:E3 ubiquitin ligase, SCF complex, Skp subunit 3.13E-08 34.20 4.47E-07 36.35
IPR018186:Transcription factor, T-box, conserved site 6.41E-08 30.78 7.48E-04 21.81
IPR016072:SKP1 component, dimerisation 6.41E-08 30.78 7.98E-07 32.72
IPR001232:SKP1 component 1.62E-07 26.77 1.69E-06 28.45
IPR016073:SKP1 component, POZ 2.79E-07 24.63 2.64E-06 26.18
IPR000571:Zinc finger, CCCH-type 4.26E-05 15.08 1.50E-05 18.70
IPR000210:BTB/POZ-like 2.50E-04 5.42 3.71E-04 5.98
IPR013069:BTB/POZ 0.005488655 5.28 2.17E-03 6.54
Table 1.  David Functional Annotation for the down-regulated genes in 5% and 1% FDR datasets.
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whereas GO terms relating to the regulation of transcription were less significant in this smaller, more 
stringent dataset. DAVID Functional Annotation Clustering again showed enrichment of F-Box proteins 
(enrichment score = 29.35) and BTB/POZ domain proteins but the enrichment score for Transcription 
factors was only 2.55 (Table  2). Table  2 shows a list of down-regulated genes found in each of these 
three clusters from the more stringent 1% FDR dataset along with any known human homologs and the 
average fold decrease detected in the microarray.
Regulatory motif analysis. The promoter sequences of DEGs from the 5% FDR dataset were ana-
lysed to identify any potential overrepresented regulatory motifs. The RSAT (Regulatory Sequence 
Analysis Tools) suite of programs were used to retrieve sequences 500 bp upstream of the transcription 
start site (TSS) of each gene and subsequently search for overrepresented oligonucleotides within these 
sequences. The top four most significantly overrepresented motifs identified in both the 5% FDR and 
1% FDR datasets are shown in Table  3. The most significantly overrepresented motif was ATCGATA 
with over 29% of genes containing this motif. A second motif, ACGCTG, was also detected in over 20% 
of sequences. ATCGAT and TATCGA are accessory motifs which often co-occurred with ATCGATA 
and were found in ~40% of promoter sequences (Table  3 and Supplementary Table S2). Enrichment 
of both unique motifs was further confirmed using SCOPE motif finder. These motifs were submitted 
to TOMTOM for comparison against a database of known nematode motifs, however no significant 
matches were found. DAVID functional annotation clustering analysis showed enrichment for F-Box 
and BTB domains in the genes containing the motifs related to ATCGATA and also to a lesser extent in 
genes containing the ACGCTG motif (Table 3 and Supplementary Table S2).
Functional validation of UPS pathway involvement. Analysis of the microarray data revealed 
an enrichment for F-Box, SKR and BTB proteins which are all components of cullin-based multimeric 
RING finger E3 ubiquitin ligase complexes32. Cullins are a conserved family of E3 ligase components, of 
which there are 6 in C. elegans (CUL1 to 6). F-Box and SKR proteins are key components of SCF-type E3 
ligase complexes which contain CUL1. SKR proteins bind to CUL1 and act as adaptor proteins recruiting 
an F-Box substrate-recognition subunit which positions target proteins to allow their ubiquitylation32 
(Fig. 2A). BTB proteins, on the other hand, can act in a different type of E3 ligase complex which con-
tains CUL3. In this complex the BTB protein acts as both the adaptor and the substrate-recognition sub-
unit combined (Fig. 2B)32. 326 F-Box, 21 skr and over 100 btb genes have been described in C. elegans32 
of which 44 F-Box, 7 skr and 16 btb transcripts were shown to be down-regulated in dnj-14 mutant 
strains. This broad reduction in the transcription of E3-ligase related genes suggests that there may be 
an overall decrease in ubiquitin-proteasome pathway activity.
To investigate this, we studied the specific turnover of a GFP tagged ubiquitin-fusion degradation 
(UFD) substrate in N2 and dnj-14 (tm3223) worms. Follow up analyses were performed on dnj-14 
(tm3223) worms only due to the confinement of the tm3223 mutation within the dnj-14 gene compared 
to the ok237 deletion which also disrupts the neighbouring gene, glit-1.
PP563 worms stably express the UFD substrate, a non-cleavable ubiquitin fused N-terminally to GFP 
(UbV-GFP), under the sur-5 promoter which is active in most tissues in C. elegans33. Under normal 
conditions UbV-GFP should become polyubiquitinated and targeted to the proteasome for degrada-
tion, however, if the UPS system is compromised this can lead to accumulation of UbV-GFP and can 
be measured by monitoring GFP fluorescence. UbV-GFP expression in C. elegans can be stabilized by 
mutating the ubiquitylation target residues K29 and K48 to arginine residues33. PP545 worms express 
K29,48RUbV-GFP under the control of the sur-5 promoter. It has been previously demonstrated that inhi-
bition of the proteasome through bortezamib treatment stabilizes UbV-GFP where as the drug has no 
effect on levels of the K29,48RUbV-GFP variant which is constitutively accumulated33,34. We performed 
experiments to monitor the accumulation of UbV-GFP in PP563 and PP545 strains after overnight incu-
bation with or without 10 μ M bortezomib. There was no GFP detected in untreated PP563 worms but a 
signal was detectable after bortezomib treatment. In contrast, as expected, GFP was already accumulated 
in PP545 worms before treatment. Quantitation showed that the average GFP signal from PP545 worm 
lysates after bortezomib treatment was 94% + /− 0.005% (+ /−SEM) compared to untreated PP545 
worms (n = 3). This illustrates that non-ubiquitylated GFP would not be otherwise targeted to the pro-
teasome when expressed under the sur-5 promoter.
Next PP563 worms, were crossed with dnj-14 (tm3223) and lines selected based on the presence or 
absence of the tm3223 allele using PCR analysis. Immuno-blotting of lysates from these worms showed 
an increased accumulation of UbV-GFP in day 1 adult dnj-14 (tm3223); PP563 worms compared to 
dnj-14 (wt); PP563 as evidenced by detection with an anti-GFP antibody (average intensity increase of 
354 + /−  109% (+ /−SEM), Fig.  3A). UbV-GFP expressing worms were also challenged with the 26S 
proteasome inhibitor, bortezomib, overnight at concentrations ranging from 0 to 12.5 mM. Bortezomib 
treatment was used to enhance the observed proteasomal dysfunction and better report the extent to 
which UPS function is reduced in dnj-14 mutant worms. GFP accumulation was detected either by 
imaging GFP fluorescence (Fig.  3B) or by immuno-blotting using an anti-GFP antibody (Fig.  3C,D). 
Again, higher GFP fluorescence was observed in dnj-14 (tm3223) worms compared to dnj-14 (wt) even 
in the absence of proteasome inhibitor (Fig.  3B). When challenged with proteasome inhibitor, dnj-14 
(tm3223) worms exhibited accumulation of UbV-GFP at bortezomib concentrations of 0.5 mM whereas 
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Cluster Ensembl ID Gene Name Human Orthologue Average Fold Change
F-BOX proteins 
(Enrichment 
Score = 29.35)
F58E1.5 fbxb-17 — 2.58
M116.4 sdz-25 — 2.16
K05F6.7 fbxb-54 — 2.08
F53C3.2 fbxb-103 — 2.00
Y51H7BR.2 fbxb-43 — 1.97
R17.1 fbxb-85 — 1.97
F08D12.10 sdz-9 — 1.97
Y43B11AL.1 Y43B11AL.1 — 1.91
T26E3.5 T26E3.5 — 1.87
ZC204.7 fbxb-15 — 1.87
R08C7.9 fbxb-74 — 1.81
F45C12.5 fbxb-11 — 1.80
F58E1.14 fbxb-47 — 1.80
W04A8.5 W04A8.5 — 1.78
F58E1.8 fbxb-18 — 1.78
M01D1.8 fbxb-41 — 1.78
T08E11.6 fbxb-10 — 1.74
F55C9.13 fbxb-63 — 1.73
ZC204.9 fbxb-20 — 1.70
F56G4.3 pes-2.1 — 1.68
F12E12.10 fbxb-90 — 1.68
M151.5 fbxb-31 — 1.66
W04A8.3 W04A8.3 — 1.65
C52E2.1 fbxb-95 — 1.65
C39B5.2 C39B5.2 — 1.64
Y46G5A.8 Y46G5A.8 — 1.63
H24O09.2 fbxb-72 — 1.60
F36H5.8 F36H5.8 — 1.60
T26E3.8 T26E3.8 — 1.59
F08D12.9 sdz-10 — 1.53
F55C9.8 fbxb-62 — 1.51
F45D11.13 fbxb-30 — 1.50
F49B2.2 fbxb-67 — 1.48
T16A1.8 fbxb-37 — 1.48
Y113G7B.8 fbxb-59 — 1.44
T17A3.4 fbxb-82 — 1.43
C08F1.3 fbxb-13 — 1.41
C36C9.3 fbxa-170 — 1.40
BTB/POZ 
domain proteins 
(Enrichment 
Score = 4.22)
M01D1.3 btb-11 — 2.07
R52.1 sdz-28 Isoform 2 of Kelch-like protein 28 2.04
K02E7.9 btb-10 — 1.87
Y105C5B.13 skr-10 Isoform 1 of S-phase kinase-associated protein 1 1.87
C52D10.8 skr-13 Uncharactersised protein 1.85
B0281.5 B0281.5 potassium channel tetramerization domain containing 10 1.85
Continued
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dnj-14 (wt) worms showed accumulation of UbV-GFP only at drug concentrations of 2.5 mM and above 
(Fig. 3B–D). dnj-14 (tm3223) worms also consistently showed a higher intensity of GFP in both imaging 
and immunoblotting experiments after bortezomib treatment (Fig. 3D, p < 0.02). This higher sensitivity 
to proteasome inhibition is indicative that ubiquitylated protein degradation is indeed compromised 
in dnj-14 (tm3223) worms. The downregulation of key components of E3 ubiquitin ligase complexes 
may have prevented proper ubiquitylation and efficient targeting of substrates for degradation by the 
proteasome.
Discussion
A high representation of E3 ubiquitin ligase components, including skr genes, F-Box genes and btb 
domain containing genes, were observed to be down-regulated in dnj-14 deficient animals compared to 
Cluster Ensembl ID Gene Name Human Orthologue Average Fold Change
F54D10.1 skr-15 Uncharactersised protein 1.75
C52D10.7 skr-9 Isoform 1 of S-phase kinase-associated protein 1 1.74
Y47D7A.8 skr-14 Uncharactersised protein 1.69
F45C12.6 btb-8 — 1.64
C52D10.9 skr-8 Isoform 1 of S-phase kinase-associated protein 1 1.61
C40A11.2 C40A11.2 potassium channel tetramerization domain containing 10 1.54
ZC204.3 btb-12 — 1.50
F45C12.7 btb-6 — 1.50
Transcription 
Factors 
(Enrichment 
Score = 2.55)
Y47D3A.12 tbx-37 T-box transcription factor TBX21 2.26
ZK662.4 lin-15B Isoform 1 of Uncharacterized protein C6orf132 2.23
C24H11.3 tbx-38 TBX6 2.00
Y46E12A.4 Y46E12A.4 Eomesodermin homolog 1.88
F17A2.5 ceh-40 pre-B-cell leukemia homeobox 1 1.68
F40H6.4 tbx-11 T-box transcription factor TBX21 1.67
C29F7.4 fkh-3 Uncharactersised protein 1.67
C32F10.6 nhr-2 highly similar to Retinoic acid receptor gamma-2 1.63
C50F4.6 his-41 Histone H2B type 1-L 1.57
F19F10.5 ets-7 Isoform 2 of ETS domain-containing protein Elk-4 1.56
C30A5.2 rfs-1 Isoform 1 of DNA repair protein RAD51 homolog 4 1.41
F19B10.9 sea-1 Isoform 1 of T-box transcription factor TBX22 1.37
ZC376.4 ceh-74 NOBOX oogenesis homeobox 1.29
ZC204.2 duxl-1 double homeobox protein 4-like protein 4 1.27
Table 2.  DAVID Functional Annotation Clustering gene list for down-regulated genes in the 1% FDR 
dataset. The enrichment score for each cluster is given in the first column and the average fold decrease for 
the two dnj-14 mutants compared to the two control strains is given in the last column.
Motif ID Exp Occ (%)
5% FDR 1% FDR Enrichment Score
Occ (%) P-Value Score
Occ 
(%) P-Value Score F-Box BTB
atcgata atcgata|tatcgat 8 29 1.70E-26 21.84 33 1.40E-21 16.95 14.24 2.98
atcgat atcgat|atcgat 15 39 3.10E-23 19.19 44 6.50E-21 16.87 19.4 4.53
tatcga tatcga|tcgata 20 40 3.80E-17 13.11 43 1.20E-17 13.62 22.47 3.39
acgctg acgctg|cagcgt 6 20 1.10E-14 10.65 23 4.90E-15 11 3.47 —
Table 3.  Regulatory motif analysis. The four most significantly overrepresented motifs in both the 5% 
and 1% FDR datasets (up- and down-regulated genes combined) are shown in this table. Lists of genes 
containing each of these motifs were analysed by DAVID functional clustering analysis and an enrichment 
score for F-Box and BTB proteins was generated. Exp Occ = expected occurrence, Occ = actual occurrence. 
The score was generated by RSAT indicating the degree of overrepresentation in the dataset.
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control nematodes in this study with these classes of genes representing 37% of the total down-regulated 
genes in the 1% FDR dataset. SKR, F-Box and BTB proteins are intrinsic to multimeric RING E3 ligases 
which contain CUL1 or CUL3 and bind a substrate protein bringing it into close proximity of an E2 
ligase to allow ubiquitylation35. The broad down-regulation of these genes indicates an involvement for 
the UPS and protein homeostasis in CSP deficient worms. Due to the specific function of CSP in syn-
aptic maintenance it would be interesting to investigate the contribution of neuronal-specific transcript 
alterations to the global changes observed in this microarray screen. Unfortunately, the small size of the 
nematode limits access to individual cell-types for molecular analysis and while some researchers have 
described methods to isolate specific cells in embryonic cultures36 and larvae37,38, this is not yet possible 
in adult populations which would be most applicable to our aging and neurodegeneration model.
Analysis of the promoter sequences for DEGs common to both control sets revealed two potential 
regulatory motifs, ATCGATA and ACGCTG. Studies identifying DNA binding motifs for transcription 
factors in C. elegans is currently limited and comparison to a database of known binding motifs did not 
identify any potential C. elegans regulatory factors. When literature searches were performed, however, 
the mammalian transcription factor, Cux1, was found to bind to the ATCGAT motif. Cux1 is a CUT 
homeodomain protein which is known to have the consensus sequence ATCGAT39. ceh-44 is an ortho-
logue of Cux1 in C. elegans and was found to be down-regulated in dnj-14 mutants compared to both 
of our control microarray datasets. In Drosophila the Cux1 homolog, Cut, functions as a determinant of 
cell-type specification of a number of tissues including in the peripheral nervous system and is a target 
of the Notch signalling pathway40.
Our research also revealed that dnj-14 mutant worms expressing a GFP tagged UFD substrate showed 
higher sensitivity when challenged with the proteasomal inhibitor, bortezomib, as evidenced by the accu-
mulation of UbV-GFP at lower drug concentrations than in control worms. This effect was apparent in 
day 1 worms indicating that alterations in UPS activity, in accordance with the broad down-regulation of 
UPS-related genes in older worms, were evident even in young adult worms. To try to address whether 
there is also an increased sensitivity of the UPS system specifically in the nervous system of dnj-14 
mutant worms we have also attempted to express UbV-GFP under the control of the rab-3, pan-neuronal 
promoter. Unfortunately, due to high expression levels of the reporter construct, we observed constitutive 
accumulation of the UbV-GFP probe even in wildtype nematodes, thus hindering this line of inquiry.
The observed changes to the UPS in our study appear at odds with previous observations from CSP 
KO mice where the expression of proteins involved in proteasomal degradation was increased and a 
broad enhancement of proteasomal activity was observed21. This observation was based on immunob-
lotting for a select few proteasomal proteins and fluorometry-based activity assays of the proteasomal 
active sites but did not examine components of multimeric E3 ubiquitin ligases. It is possible, therefore, 
that the increased breadth and sensitivity offered by microarray analysis has highlighted subtle changes 
in the C. elegans dnj-14 deficient models that were not identified in CSP KO mice.
In CSP KO mice, an increase in UPS-related protein expression was observed, which was coupled 
with a ~40% increase in SNAP-25 ubiquitylation and enhanced proteasomal activity21. Misfolded neu-
rotoxic proteins are often ubiquitylated and targeted for degradation in age-related neurological dis-
orders and it is thought that this might be a protective mechanism by which brain cells try to cope 
with neurodegeneration. Sharma et al., however, observed a therapeutic effect of proteasomal inhibitors, 
lactacystin and epoxomicin, in CSP-depleted mice due to a ~2-fold increase in levels of SNAP-25 and 
SNARE complex assembly21. Conformational quality control of SNAP-25 is crucial for the maintenance 
of high frequency synaptic activity. This quality control process exists in equilibrium between chaperone 
Figure 2. Schematic diagrams illustrating the composition of multimeric RING E3 Ubiquitin ligases. 
(A) SCF complex containing CUL1, (B) BTB complex containing CUL3.
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Figure 3. dnj-14 (tm3223) worms are delayed in ubiquitylated protein degradation (A) Representative 
image of Western blot detection of GFP-UbV accumulation in PP563 and PP545 strains after overnight 
incubation with or without 10 μM bortezomib. There was no GFP detected in untreated PP563 worms but 
a signal was detectable after bortezomib treatment. In contrast GFP was already accumulated in PP545 
worms before treatment. Quantitation using ImageJ showed that the average GFP signal from PP545 worm 
lysates after bortezomib treatment was 94% + /− 0.005% (+ /−SEM) compared to untreated PP545 worms 
(n = 3). (B) Representative image of Western blot detection of GFP-UbV accumulation in N2 and dnj-14 
(tm3223) crossed with the pSur5::UbV-GFP expressing strain, PP563, generating the strains, dnj-14 (wt); 
PP563 and dnj-14 (tm3223); PP563. There was an average intensity increase of 354 + /− 109% (+ /−SEM) 
in dnj-14 (tm3223); PP563 compared to dnj-14 (wt); PP563 (n = 3). Worms were harvested and lysed at day 
1 of adulthood. 50 worms were lysed in each SDS-PAGE sample and anti-beta-actin was used as a loading 
control. (B) GFP fluorescence was imaged in dnj-14 (wt); PP563 and dnj-14 (tm3223); PP563 worms after 
overnight incubation with increasing concentrations of bortezomib. (C) Western blot detection of GFP-
UbV accumulation, using an anti-GFP antibody, after overnight treatment of dnj-14 (wt); PP563 and dnj-14 
(tm3223); PP563 with increasing concentrations of bortezomib. (D) Quantitation of anti-GFP signal detected 
in (C). Band intensity for 0 mM was assumed to be background and was subtracted from the band intensity 
for drug treated samples for the corresponding strain. All data was then normalised against the signal for 
dnj-14 (wt); PP563 at 0.5 mM. Error bars represent the standard error of the mean. Use of ANOVAR showed 
that data from the dnj-14 (tm3223) worms was statistically significantly different from the control worm data 
(n = 3, p < 0.02).
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mediated refolding by CSP which promotes SNARE complex assembly, and UPS-dependent degradation 
which reduces SNAP-25 levels and hence decreases synaptic activity. In CSP deficient mice, proteasomal 
inhibition can shift the balance away from SNAP-25 degradation and help maintain more functional 
SNARE complexes and hence synaptic activity21. We tested the effect of proteasome inhibition in dnj-14 
(tm3223) worms by monitoring the lifespan of nematodes grown in the presence of either 0.5 μ M or 
2.5 μ M bortezomib, however, we did not observe any significant difference compared to vehicle treated 
controls (data not shown). In C. elegans it appears that a protective mechanism may have evolved nat-
urally through the downregulation of UPS-pathway genes without the need for additional proteasome 
inhibitor treatment. Selective pressures acting on the dnj-14 mutant worms over many generations may 
have allowed a compensatory reduction in UPS activity which would not be possible in first generation 
CSP−/− KO mouse models. We propose that a reduction in the expression of RING finger E3 ubiquitin 
ligase components reduces the ubiquitylation and degradation of essential synaptic proteins such as RIC-
4, the C. elegans homolog of SNAP-25. Unfortunately, this theory could not be directly tested as both 
a polyclonal SNAP-25 antibody and a custom made polyclonal RIC-4 antibody, failed to give a specific 
signal when C. elegans lysates were immunoblotted.
The action of E3 ligases in different organisms has been previously shown to affect the stability and 
localisation of various aging-related genes including almost all components of the insulin/insulin-like 
growth factor-1 (IGF-1)-signalling (IIS) pathway41. Additionally, A number of studies have identified 
connections between the UPS pathway and age-related processes in C. elegans. Ghazi et al. previously 
performed an RNAi screen of C. elegans proteasomal subunits and SCF complex components to identify 
factors which affect lifespan42. In this screen they found that a CUL1 E3 ligase SCF complex is required 
for lifespan extension of C. elegans’ IIS pathway mutants. They speculate that this CUL1 complex could 
ubiquitylate and degrade one or more proteins that actively regulate the rate of aging42. In another study 
Kuhlbrodt et al. found that loss of a deubiquitinating enzyme, ATX-3, and the ubiquitin-selective chap-
erone, CDC-48, leads to lifespan extension by stabilizing components of the IIS pathways thus activating 
transcription of DAF-16 targets43.
A study examining the gene profile of C. elegans at mid-life transition (day 5 adult worms) identified a 
group of genes and compared these to those which had been found in other age-related studies44. Of the 
total DEGs identified in the present study 19 (6.6%) were present within the combined analysis reported 
by Eckley et al. These authors suggest that targeted proteolysis is essential during the onset of senescence 
in post-developmental animals and 42% of the differentially expressed UPS related genes at midlife 
transition were common to those differentially expressed in dnj-14 mutants. While there is, therefore, 
some overlap with known ageing-related genes, many of the differentially regulated UPS-related genes 
identified in dnj-14 mutants are unique to our study. This indicates that the changes were not simply a 
consequence of premature aging in dnj-14 mutants and alternative non-ageing related processes might 
be activated in these worms.
This study has revealed a genetic interaction between dnj-14 and UPS system regulation resulting in 
down-regulation of multiple E3 ligase components and decreased ubiquitylated protein degradation. The 
UPS has received a lot of attention in relation to the study of neurodegenerative diseases however there 
has been a lack of consensus about whether UPS activity is increased or decreased in these disorders2. 
Likewise, reports are varied about whether direct proteasomal inhibition is detrimental or beneficial 
depending on the disease or system being studied2. For example, inhibition of proteasome activity has 
been shown to be beneficial in protection of β -amyloid neurotoxicity45, as well as in the CSP-deficient 
mouse model. Treatment with proteasomal inhibitors can, however, itself result in neurodegeneration46. 
Instead, our results hint that therapeutics specifically targeting proteins and complexes, such as E3 ubiq-
uitin ligases, which act upstream of the 26S proteasome, may be beneficial as potential pharmacological 
targets for the treatment of neurodegenerative diseases including ANCL. Indeed, a number of ubiquitin 
ligases have been identified as promising drug targets47–49 and progress has been made toward developing 
specific inhibitors of SCF complexes in particular50–57.
Methods
Strains. C. elegans strains RM2754 dnj-14 (ok237) and CZ1200 juIs76 [unc-25p::GFP + lin-15(+ )] 
II were obtained from the Caenorhaditis Genetics Center (CGC; University of Minnesota, Twin Cities, 
MN, USA). The TM3223 dnj-14 (tm3223) strain was obtained from the National Bioresource Project for 
the Experimental Animal “Nematode C. elegans” based in the lab of Dr Shohei Mitani (Tokyo Women’s 
Medical University, Tokyo, Japan). PP563 unc-119(ed4)III; hhIs64 [unc-119(+ ); sur-5::UbV-GFP]III and 
PP545 unc-119(ed4)III; hhIs53 [unc-119(+ ); sur-5::K29/48R-UbV-GFP] were a kind gift from the lab of 
Professor Hoppe (University of Cologne, Germany).
Strain Construction and Verification. TM3223 transgenic strains expressing sur-5::UbV-GFP were 
generated by mating the TM3223 dnj-14( tm3223) with PP563 unc-119(ed4)III; hhIs64 [unc-119(+ ); 
sur-5::UbV-GFP]III. Worms expressing GFP were selected and PCR was used to verify the presence of 
the tm3323 allele using primers as described previously25.
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Nematode culture. C. elegans were grown at 20 °C under standard conditions on nematode growth 
media (NGM; 2% (w/v) agar, 0.3% (w/v) NaCl, 0.25% (w/v) peptone, 1 mM CaCl2, 5 μ g ml−1 cholesterol, 
25 mM KH2PO4, 1 mM MgSO4) agar plates. Escherischia coli OP50 was used as a food source. All exper-
iments were performed at 20 °C.
Microarray Analysis. N2, CZ1200, dnj-14 (ok237) and dnj-14 (tm3223) strains were first age syn-
chronised by bleaching. Worms were then grown for 2 days after L4 stage (day 2 of adulthood) and 
50 hermaphrodites of each strain were transferred to new plates and allowed to lay eggs for 6 hours 
before removal. After hatching worms were grown until L4 stage then 400 hermaphrodites from each 
strain were picked onto fresh plates. Worms were transferred onto fresh plates on alternate days until 
day 6 of adulthood when worms were harvested by washing plates with DNase/RNase-free distilled 
water (Invitrogen). Total RNA was extracted using TRIzol reagent (Invitrogen) and purified using Qiagen 
RNAeasy Mini Kit (Qiagen). Three biological replicates were prepared for each of the four strains used 
and hybridised to Affymetrix C. elegans GeneChip arrays according to the manufacturer’s instructions.
Data generation and diagnostic analysis. Initial diagnostic and differential expression analysis of 
the microarray data was performed using the statistical analysis tools R, Affy (version 2.15.2) and limma 
(version 3.14.4). Background correction and normalisation of raw Affymetrix array data were conducted 
using the Robust Multi-array Average function built into the Affy package58. The significance test of the 
estimated logFC (log2 Fold Change) for each contrast was performed by the empirical Bayes function 
packed in limma and p-values were adjusted using the Benjamini and Hochberg FDR control approach 
to deal with the effect of multiple tests59.
Gene Ontology Analysis. Data were analysed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID) V6.7 from the National Institutes of Health60,61. A gene list for analy-
sis was generated by submitting the affymetrix C. elegans probe IDs of commonly regulated DEGs to 
DAVID for conversion to Ensembl Gene IDs and any duplicates were removed. For GO Term analysis, 
the “Biological Process”, “Cellular Component” and “Molecular Function” categories were studied using 
the GO FAT default settings. Protein domain and pathway enrichment were investigated using DAVID 
by querying the Interpro and KEGG databases, respectively. Functional annotation clustering was per-
formed with the default criteria at medium classification stringency. Human orthologues of the corre-
sponding worm genes were derived from either wormbase62 or the OrthoList online tool63.
Motif analysis. The Regulatory Sequence Analysis Tools suite (RSAT)64 was first used to retrieve 
sequences 500 bp upstream of the TSS for all genes in the 5% FDR dataset. This was subsequently sub-
mitted to the RSAT oligo analysis tool65 to identify overrepresented motifs in the sequences. To confirm 
enrichment of these motifs, gene names were submitted to SCOPE motif finder66 specifying sequences 
400 bp upstream of the TSS. In each case sequences were examined for oligonucleotides of 6–8 bases 
in length.
Bortezomib experiments. To test the effect of bortezomib treatment on PP563 and PP545 strains, 50 
worms of either strain were picked into tubes of 100 μ l S-Basal solution (100 mM NaCl, 6 mM K2HPO4, 
44 mM KH2PO4, 5 μ g/ml cholesterol) containing OP50 as a food source, with or without 10 μ M borte-
zomib. Worms were incubated with gentle shaking overnight at 20 °C. Worms were then washed in 
S-basal solution and the worms were allowed to settle to the bottom of the tube. Excess supernatant 
was then removed and worms were analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
Bortezomib dose response experiments were conducted in the same way using either dnj-14 (wt) or dnj-
14 (tm3223) stably expressing pSur5::Ubv-GFP and increasing concentrations of bortezomib as indicated 
in the figure legends. Worms were then either imaged or analysed by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE). As treatment with increasing levels of proteasome inhibitor will affect the levels 
of many proteins within the cell, equal loading was assessed and confirmed by Ponceau S staining of 
nitrocellulose membranes prior to western blotting to visualize protein levels in whole lanes rather than 
blotting for a single housekeeping protein (see Supplementary Figure S2).
Imaging. Worms were picked into a droplet of Dents buffer (140 mM NaCl, 6 mM KCl, 1 mM CaCl2, 
1 mM MgCl2, 5 mM HEPES, pH 7.4 with bovine serum albumin at 0.1 mg/ml) before imaging using a 
Nikon Eclipse Ti S fluorescence microscope with a × 20 objective and processed using the software NIS 
Elements.
Protein electrophoresis and western blot analysis. Worm lysates were prepared in SDS loading 
buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue and 0.125 M Tris HCl, 
pH 6.8), vortexed for 1 minute before freezing at − 80 °C and boiled at 95 °C for 20 minutes. Samples were 
separated by SDS-PAGE on NuPAGE® Novex® 4–12% bis-tris gels using NuPAGE® MOPS SDS run-
ning buffer (Invitrogen). The fractionated proteins were then transferred to nitrocellulose membranes, 
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which were then blocked in 0.5% fish skin gelatin (sigma) in PBS for 1 hour at room temperature. The 
membranes were subsequently incubated with mouse anti-GFP (roche) for 1 hour at room temperature. 
Membranes were subsequently incubated with mouse anti-beta-actin (sigma) for 1 hour at room tem-
perature as a loading control. IRDye conjugated secondary antibody, anti-mouse 680RD (LI-COR), was 
incubated with membranes for 1 hour at room temperature before imaging with an Odyssey Sa infrared 
imaging system (LI-COR). The relative abundance of GFP levels was quantified using either Image Studio 
Lite (LI-COR) or ImageJ.
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Supplementary Figure S1 
Whole-genome expression profiling of dnj-14(ok237), dnj-14(tm3223), CZ1200 
and N2 strains. A) Principal component analysis (PCA) plot of transcription profiles 
of all four strains. The PCA plot shows the distance between profiles and denotes the 
similarities or dissimilarities between each strain. All three biological replicates in 
each condition show a high reproducibility. (B) Pearson correlation coefficient-based 
heat-map of expression similarity and divergences among the four strains based on 
genes that showed significant correlations. All three biological replicates are shown 
independently for each condition. Samples are clustered along both axes based on 
their correlation value and the diagonal of the heat-map indicates the amount of the 
Pearson correlation between corresponding sample types. High covariance is 
indicated in dark red, low covariance is indicated in dark blue. Yellow and green 
regions indicate weak correlations/uncorrelated assets (see colour bar).  
 
Supplementary Figure S2 
Representative loading controls for figures 3A and 3D. A) Ponceau S stained 
nitrocellulose membrane showing equal loading of PP563 and PP545 samples with 
and without bortezomib treatment as in figure 3A. B) Ponceau S stained nitrocellulose 
membrane showing equal loading of samples from a bortezomib dose response 
experiment as seen in figure 3D. 
 
Supplementary Table S1.xls 
Differentially expressed genes. Gene list of differentially expressed genes which 
were up or down regulated in both dnj-14 (tm3223) and dnj-14 (ok237) compared to 
both controls, N2 and CZ1200.  
 
Supplementary Table S2.xls  
Regulatory motif analysis. List of genes containing the top four most significantly 
overrepresented motifs within their promoter regions (500bp upstream of the TSS). Y 
= motif is found in this promoter sequence. N = motif is not found in this promoter 
sequence.	  
